Neuro-oncologist Aaron Mammoser Clinical Trial Update

Neuro-oncologist Aaron Mammoser Clinical Trial Update

LSU Neuro-oncology Research UpdateПодробнее

LSU Neuro-oncology Research Update

Clinical Trials for Brain and Spine TumorsПодробнее

Clinical Trials for Brain and Spine Tumors

ABTA Panel: Moving the Needle: Clinical Trials in Neuro-OncologyПодробнее

ABTA Panel: Moving the Needle: Clinical Trials in Neuro-Oncology

Clinical Trials for Brain TumorsПодробнее

Clinical Trials for Brain Tumors

Neuro-Oncology Conversations: Brain Tumor Clinical TrialsПодробнее

Neuro-Oncology Conversations: Brain Tumor Clinical Trials

Neuro-oncologist Aaron Mammoser, MDПодробнее

Neuro-oncologist Aaron Mammoser, MD

Get to know your LCMC Health Neuroscience care team | Aaron Mammoser, MDПодробнее

Get to know your LCMC Health Neuroscience care team | Aaron Mammoser, MD

Aaron Mammoser, MD - Video ProfileПодробнее

Aaron Mammoser, MD - Video Profile

Brain Tumor DiagnosisПодробнее

Brain Tumor Diagnosis

Managing Neuro-oncology Care Amid Covid-19Подробнее

Managing Neuro-oncology Care Amid Covid-19

Get into clinical trialsПодробнее

Get into clinical trials

New Approaches to Clinical Trials in Neuro Oncology by Mark GilbertПодробнее

New Approaches to Clinical Trials in Neuro Oncology by Mark Gilbert

Insights into the Phase III CERVINO trial: ABBV-383 for R/R myelomaПодробнее

Insights into the Phase III CERVINO trial: ABBV-383 for R/R myeloma

Incorporation of BRAF–Targeted Therapy into Neuro Oncology Clinical Practice - Karisa Schreck, M.D.Подробнее

Incorporation of BRAF–Targeted Therapy into Neuro Oncology Clinical Practice - Karisa Schreck, M.D.

Why neuro-oncologists are uniquely qualified to help brain tumor patientsПодробнее

Why neuro-oncologists are uniquely qualified to help brain tumor patients

Cancer Disappears In All Patients During Immunotherapy Drug TrialПодробнее

Cancer Disappears In All Patients During Immunotherapy Drug Trial

Update on the ENERGIZE trial of mitapivat in NTD alpha- and beta-thalassemiaПодробнее

Update on the ENERGIZE trial of mitapivat in NTD alpha- and beta-thalassemia